Fresenius Kabi Canada announces that its tocilizumab biosimilar Tyenne ® referencing Actemra ®** (tocilizumab) is now commercially available in Can ...

The biologic drug tocilizumab (Actemra) has a new competitor since its patent recently expired in the U.S., although it is not yet available in this country. Having another option to treat sJIA is a ...